| Emerging Vaccine Immunotherapy In NSCLC: The Adverse Reactions of Recent Clinical Trials and Future Directions | | |
| PD-1/PD-L1 inhibitors in treatment-naïve, advanced non-small cell lung cancer patients with < 1% PD-L1 expression: a meta-analysis of randomized controlled trials | | |
| The role of immunotherapy plus chemotherapy versus chemotherapy alone as first-line treatment for advanced non-small cell lung cancer: an updated systematic review and meta-analysis of randomized controlled trials | | |
| The Blood Proteome of Imminent Lung Cancer Diagnosis | | |
| Sputum analysis by flow cytometry; an effective platform to analyze the lung environment | | 2022 |
| Immune Checkpoint Inhibitor Rechallenge Safety and Efficacy in Stage IV Non-Small Cell Lung Cancer Patients After Immune-Related Adverse Events | | 2022 |
| TRAIL-induces Src mediated MEK/ERK, SMAD3 and β-catenin signalling in apoptosis resistant NSCLC cells | | |
| Emerging Approaches to Complement Low-Dose Computerized Tomography for Lung Cancer Screening: A Narrative Review | | 2022 |
| Evaluation of Lung Cancer Incidence Dynamics in Kyrgyzstan | | 2022 |
| Current challenges of unresectable stage III NSCLC: are we ready to break the glass ceiling of the PACIFIC trial? | | 2022 |
| Management of screen-detected lung nodule: A single-center experience | Formosan Journal of Surgery | 2022 |
| Air pollution and lung cancer survival in Pennsylvania | Lung Cancer | 2022 |
| Role of low dose computed tomography on lung cancer detection and mortality - an updated systematic review and meta-analysis | Monaldi Archives for Chest Disease | |
| Efficacy comparison of immune treating strategies for NSCLC patients with negative PD-L1 expression | Expert Review of Clinical Immunology | |
| Experimental approach to obtaining subcutaneous xenograft of non-small cell lung cancer | Issledovaniâ I Praktika V Medicine | 2022 |
| Study of biological activity of 2-quinoline-2-yl-derivative 1,3-tropolone in experiment | Issledovaniâ I Praktika V Medicine | 2022 |
| 18F-FDG PET/CT for Response Assessment in Lung Cancer | Seminars in Nuclear Medicine | 2022 |
| De- "bug"-ing the microbiome in lung cancer. | Cancer and Metastasis Reviews | 2022 |
| The state of the art for artificial intelligence in lung digital pathology. | Journal of Pathology | 2022 |
| A five-step strategy for building an LDCT lung cancer screening program | | |
| Experimental investigation of microwave holographic reflectometry for lung tumor detection | Measurement: Journal of the International Measurement Confederation | 2022 |
| Hypothesized Explanations for the Observed Lung Cancer Survival Benefit Among Hispanics/Latinos in the United States. | Journal of Racial and Ethnic Health Disparities | 2022 |
| Heavy Smoking Patients Receiving a Lung Cancer Screen Want to Quit: A Call for Tailored Cessation Interventions | Frontiers in Medicine | 2022 |
| Kliniğimizde İzlenen Akciğer Kanseri Hastalarında Klinik Özellikler ve Sağ Kalımı Etkileyen Faktörlerin Değerlendirilmesi: Zonguldak Bülent Ecevit Üniversitesi Hastanesi Örneği | Medical Journal of Western Black Sea | 2022 |
| GOECP/SEOR radiotheraphy guidelines for non-small-cell lung cancer. | World Journal of Clinical Oncology | 2022 |
| The Predictive Value of PD-L1 Expression Level in Evaluating the Cost-Effectiveness of Atezolizumab/Pembrolizumab. | Frontiers in Oncology | 2022 |
| Table_7.docx | | 2018 |
| Table_6.docx | | 2018 |
| Table_5.docx | | 2018 |
| Table_4.docx | | 2018 |
| Table_3.docx | | 2018 |
| Table_2.docx | | 2018 |
| Table_1.DOCX | | 2018 |
| Image_9.pdf | | 2018 |
| Image_8.PDF | | 2018 |
| Image_7.PDF | | 2018 |
| Image_6.PDF | | 2018 |
| Image_5.PDF | | 2018 |
| Image_4.PDF | | 2018 |
| Image_3.PDF | | 2018 |
| Image_2.PDF | | 2018 |
| Image_1.PDF | | 2018 |
| Data_Sheet_1.DOCX | | 2018 |
| Table_1.DOCX | | 2020 |
| Image_4.jpeg | | 2019 |
| Image_3.jpeg | | 2019 |
| Image_2.jpg | | 2019 |
| Image_1.JPEG | | 2019 |
| Inflammatory Respiratory Diseases: Correlation Between Lung Cancer and COVID-19 | | 2022 |
| Real-World Outcomes Among Crizotinib-Treated Patients with ROS1-Positive Advanced Non-Small-Cell Lung Cancer: A Community Oncology-Based Observational Study. | Targeted Oncology | 2021 |
| A potential treatment option for advanced non-small cell lung cancer: Three cases. | Explore: the Journal of Science and Healing | 2022 |
| 18F-FSPG PET imaging for the evaluation of indeterminate pulmonary nodules. | PLoS ONE | 2022 |
| Perceptions of somatic and affective symptoms and psychosocial care utilization in younger and older survivors of lung cancer. | Supportive Care in Cancer | 2022 |
| Spatial assessment of advanced-stage diagnosis and lung cancer mortality in Brazil. | PLoS ONE | 2022 |
| Combination of Nutritional Risk Index and Handgrip Strength on the Survival of Patients with Cancer Cachexia: A Multi- Center Cohort Study. | Journal of Inflammation Research | 2022 |
| Healthcare Utilization Disparities Among Lung Cancer Patients in US Hospitals During 2010-2014: Evidence from the US Hispanic Population's Hospital Charges and Length of Stay. | International Journal of General Medicine | 2022 |
| Thoracoscopic Lobectomy Versus Sublobar Resection for pStage I Geriatric Non-Small Cell Lung Cancer. | Frontiers in Oncology | 2021 |
| Real-world treatment patterns in resectable (stages I-III) non-small-cell lung cancer: a systematic literature review. | Future Oncology | 2022 |
| Triglyceride-Glucose Index Is Not Associated With Lung Cancer Risk: A Prospective Cohort Study in the UK Biobank | Frontiers in Oncology | 2021 |
| Estimating the Financial Impact of Gene Therapy* | | |
| Behavioral Risk Factors: A Guide for Oncology Nurses Counseling Patients | Clinical Journal of Oncology Nursing | 2020 |
| Lessons for Precision Medicine from Lung Cancer | Respiratory Medicine | 2020 |
| Preisbildung von Pharmaprodukten | | 2020 |
| Endoscopic restoration of the left lung main bronchi for unresectable metastatic cancer complete obstruction | Endoscopic Surgery | 2020 |
| Respiratory support for endoscopic operations on the larynx, trachea, bronchi | Onkologiya Zhurnal Imeni P A Gertsena | 2020 |
| Immune checkpoint blockade in the treatment of advanced non-small cell lung cancer - predictors of response and impact of previous radiotherapy | Acta Oncológica | 2021 |
| Principles of Cancer Surgery in Older Adults | | 2020 |
| Malignant Epithelial Tumors of the Lung | | 2020 |
| Flexible Bronchoscopy and the Application of Endobronchial Brachytherapy, Fiducial Placement, Radiofrequency Ablation, and Microwave Ablation | | 2020 |
| Factors affecting delay in diagnosis and treatment of lung cancer | Journal of Surgery and Medicine | 2019 |
| Stromal Hedgehog pathway activation by IHH suppresses lung adenocarcinoma growth and metastasis by limiting reactive oxygen species | | |
| A Model-Based Cost-Effectiveness Analysis of an Exercise Program for Lung Cancer Survivors Following Curative-Intent Treatment | | |
| CLINICAL AND CYTOMORPHOLOGICAL EVALUATION OF PRIMARY LUNG NEOPLASMS IN A TERTIARY CARE TEACHING CENTRE OF SOUTH INDIA | Journal of Evolution of Medical and Dental Sciences | 2017 |
| Principles of Cancer Surgery in Older Adults | | 2017 |
| Gene Signature | | 2017 |
| Lung Cancer | | 2016 |
| Mass Screening for the Early Detection of Lung Cancer | Japanese Journal of Lung Cancer | 2014 |
| Carcinoma/Undifferentiated Tumor | | 2014 |
| Molecular Pathology of Lung Cancers | | 2013 |
| Power Analysis for the Mean Effect Size | | 2012 |
| Racial and Ethnic Diversity in Lung Cancer | | 2010 |
| Metastatic BRAF V600E-Mutated Adenocarcinoma of the Lung Presenting as Extreme Neutrophilia and Eosinophilia | Cureus | 2021 |
| Results of Second Round Lung Cancer Screening by Low-Dose CT scan - French Cohort Study (DEP-KP80) | Clinical Lung Cancer | 2021 |
| Extended parallel process model (EPPM) in evaluating lung Cancer risk perception among older smokers | BMC Public Health | 2021 |
| Biopsy frequency and complications among lung cancer patients in the United States | Lung Cancer Management | 2020 |
| Prediction of the 1-Year Risk of Incident Lung Cancer: Prospective Study Using Electronic Health Records from the State of Maine | Journal of Medical Internet Research | 2019 |
| Combinatorial treatment using targeted MEK and SRC inhibitors synergistically abrogates tumor cell growth and induces mesenchymal-epithelial transition in non-small-cell lung carcinoma | Oncotarget | 2015 |
| The role of EGFR mutations in predicting recurrence in early and locally advanced lung adenocarcinoma following definitive therapy | Oncotarget | 2020 |
| PD-1/PD-L1 antibodies efficacy and safety versus docetaxel monotherapy in advanced NSCLC patients after first-line treatment option: systems assessment | Oncotarget | 2017 |
| Isoalantolactone induces intrinsic apoptosis through p53 signaling pathway in human lung squamous carcinoma cells | PLoS ONE | 2017 |
| Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting | PLoS ONE | 2017 |
| Identification of Gene Expression Differences between Lymphangiogenic and Non-Lymphangiogenic Non-Small Cell Lung Cancer Cell Lines | PLoS ONE | 2016 |
| PD-L1 expression correlation with metabolic parameters of FDG PET/CT and clinicopathological characteristics in non-small cell lung cancer | EJNMMI Research | 2020 |
| Epidemiology: development and perspectives | | |
| CCT6A suppresses SMAD2 and promotes prometastatic TGF-β signaling | Journal of Clinical Investigation | 2017 |
| Multiparametric profiling of non-small-cell lung cancers reveals distinct immunophenotypes | JCI Insight | 2016 |
| Enapotamab vedotin, an AXL-specific antibody-drug conjugate, shows preclinical antitumor activity in non-small cell lung cancer | JCI Insight | 2019 |
| The Influence of Social and Economic Conditions on Respiratory Health | Respiratory Medicine | 2017 |
| Aromatase Inhibitors Beyond Breast Cancer: Endometrium Versus Breast Puzzle and Other Issues | Resistance To Targeted Anti-cancer Therapeutics | 2015 |
| What Are the Numbers? The Epidemiology of Cancer by Sexual Orientation and Gender Identity | | 2015 |
| Cytology samples and molecular biomarker testing in lung cancer-advantages and challenges | Virchows Archiv Fur Pathologische Anatomie Und Physiologie Und Fur Klinische Medizin | 2021 |
| Budget impact of capmatinib for adults with metastatic non-small cell lung cancer harboring a exon 14 skipping mutation in the United States | Journal of Medical Economics | 2021 |
| Prognostic relevance of pleural invasion for resected NSCLC patients undergoing adjuvant treatments: A propensity score-matched analysis of SEER database | Lung Cancer | 2021 |
| Association between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Lung Cancer | Southern Medical Journal | 2021 |
| Single Institution Experience of Proton and Photon-based Postoperative Radiation Therapy for Non-small-cell Lung Cancer | Clinical Lung Cancer | 2021 |
| Evaluating the clinical trends and benefits of low-dose computed tomography in lung cancer patients | Cancer Medicine | 2021 |
| Real-world treatment patterns and outcomes in PD-L1-positive non-small cell lung cancer | Immunotherapy | 2021 |
| Dynamic nomograms combining N classification with ratio-based nodal classifications to predict long-term survival for patients with lung adenocarcinoma after surgery: a SEER population-based study | BMC Cancer | 2021 |
| Comparing the downstream costs and healthcare utilization associated with the use of low-dose computed tomography (LDCT) in lung cancer screening in patients with and without alzheimer's disease and related dementias (ADRD) | Current Medical Research and Opinion | 2021 |
| STYK1/NOK Promotes Metastasis and Epithelial-Mesenchymal Transition in Non-small Cell Lung Cancer by Suppressing FoxO1 Signaling | Frontiers in Cell and Developmental Biology | 2021 |
| Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy | Communications Biology | 2021 |
| Cost-Effectiveness of Lorlatinib as a First-Line Therapy for Untreated Advanced Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer | Frontiers in Oncology | 2021 |
| Pulmonary and renal tolerance of cisplatin-based regimens combining intravenous and endotracheal routes for lung cancer treatment in mice | International Journal of Pharmaceutics | 2021 |
| Identification of an Individualized Metabolism Prognostic Signature and Related Therapy Regimens in Early Stage Lung Adenocarcinoma | Frontiers in Oncology | 2021 |
| Comparison of epidermal growth factor receptor mutation detection turnaround times and concordance among real-time polymerase chain reaction, high-throughput next-generation sequencing and the Biocartis Idylla™ platforms in non-small cell lung carcinomas | Pathology Research and Practice | 2021 |
| A Comparison of Web-Based Cancer Risk Calculators That Inform Shared Decision-making for Lung Cancer Screening | Journal of General Internal Medicine | 2021 |
| A phase II study of first-line afatinib for patients aged ≥75 years with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan Study Group trial NEJ027 | BMC Cancer | 2021 |
| Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement | JAMA - Journal of the American Medical Association | 2021 |
| Association Between Anesthetic Dose and Technique and Oncologic Outcomes After Surgical Resection of Non-Small Cell Lung Cancer | Journal of Cardiothoracic and Vascular Anesthesia | 2021 |
| Identification of Proteins Deregulated by Platinum-Based Chemotherapy as Novel Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer | Frontiers in Oncology | 2021 |
| Robotic-Assisted Navigation Bronchoscopy as a Paradigm Shift in Peripheral Lung Access | Lung | 2021 |
| Residential Radon and Small Cell Lung Cancer. Final Results of the Small Cell Study | Archivos De Bronconeumologia | 2021 |
| Patient Preferences for Lung Cancer Treatment: A Qualitative Study Protocol Among Advanced Lung Cancer Patients | Frontiers in Public Health | 2021 |
| Considerations and Experience in the Treatment of Lung Cancer with VMAT SBRT + DIBH in Arms-Down Position | International Journal of Medical Physics, Clinical Engineering and Radiation Oncology | 2021 |
| Interactions Between Obesity and One-Carbon Metabolism Genes in Predicting Prostate Cancer Outcomes Among White and Black Patients | Journal of Racial and Ethnic Health Disparities | 2021 |
| Machine Learning for Prediction of Lung Cancer | Advances in Medical Technologies and Clinical Practice Book Series | 2021 |
| Cancer health disparities in racial/ethnic minorities in the United States | British Journal of Cancer | 2021 |
| Returning to work in lung cancer survivors-a multi-center cross-sectional study in Germany | Supportive Care in Cancer | 2021 |
| The rapidly evolving landscape of biomarker testing in non-small cell lung cancer | Cancer Cytopathology | 2021 |
| 2-[F]FDG PET/CT radiomics in lung cancer: An overview of the technical aspect and its emerging role in management of the disease | Methods | 2021 |
| Long-term survival trends in patients with unresectable stage III non-small cell lung cancer receiving chemotherapy and radiation therapy: a SEER cancer registry analysis | BMC Cancer | 2020 |
| Association of metastatic pattern and molecular status in stage IV non-small cell lung cancer adenocarcinoma | European Radiology | 2020 |
| Preoperative Evaluation for Lung Resection Surgery | Current Anesthesiology Reports | 2020 |
| Progression of the smoking epidemic in high-income regions and its effects on male-female survival differences: a cohort-by-age analysis of 17 countries | BMC Public Health | 2020 |
| Patterns of care for older patients with stage IV non-small cell lung cancer in the immunotherapy era | Cancer Medicine | 2020 |
| Cost-effectiveness of pembrolizumab for advanced non-small cell lung cancer patients with varying comorbidity burden | PLoS ONE | 2020 |
| Risk-Based lung cancer screening: A systematic review | Lung Cancer | 2020 |
| Population Pharmacokinetics of Erlotinib in Patients With Non-small Cell Lung Cancer: Its Application for Individualized Dosing Regimens in Older Patients | Clinical Therapeutics | 2020 |
| Analysis of Patient Preferences in Lung Cancer - Estimating Acceptable Tradeoffs Between Treatment Benefit and Side Effects | Patient Preference and Adherence | 2020 |
| Evaluating the Use of Circulating MicroRNA Profiles for Lung Cancer Detection in Symptomatic Patients | JAMA Oncology | 2020 |
| Locally Advanced, Unresectable Non-Small Cell Lung Cancer | Current Oncology Reports | 2020 |
| Differences in the clinical management of women and men after detection of a solitary pulmonary nodule in clinical practice | European Radiology | 2020 |
| Preclinical PET imaging study of lung cancer with CuCl | Annals of Nuclear Medicine | 2020 |
| The Role of Malnutrition and Muscle Wasting in Advanced Lung Cancer | Current Oncology Reports | 2020 |
| The Value of Hope: Patients' and Physicians' Preferences for Survival in Advanced Non-Small Cell Lung Cancer | Patient Preference and Adherence | 2020 |
| The role of palliative care in the management of patients with lung cancer | Lung Cancer Management | 2020 |
| Striving toward Improved Outcomes for Surgically Resectable Non-Small Cell Lung Cancer: the Promise and Challenges of Neoadjuvant Immunotherapy | Current Oncology Reports | 2020 |
| Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-Stage Small Cell Lung Cancer | Oncologist | 2020 |
| Incidental early diagnosis of biphasic pulmonary blastoma in a patient with history of stage IV lung adenocarcinoma | Thoracic Cancer | 2020 |
| A Qualitative Cultural Sensitivity Assessment of the Breathe Easier Mobile Application for Lung Cancer Survivors and Their Families | Oncology Nursing Forum | 2020 |
